BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23033288)

  • 41. Plasma TM2-PK levels in mycosis fungoides patients.
    Hapa A; Erkin G; Hasçelik G; Pektaş D; Arslan U
    Arch Dermatol Res; 2011 Jan; 303(1):35-40. PubMed ID: 20927531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.
    Duletić-Nacinović A; Stifter S; Marijić B; Lucin K; Valković T; Petranović D; Jonjić N
    Tumori; 2008; 94(4):511-7. PubMed ID: 18822687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
    Avilés A; Zepeda G; Díaz-Maqueo JC; Rodriguez L; Guzmán R; García EL; Talavera A
    Leuk Lymphoma; 1992 May; 7(1-2):135-8. PubMed ID: 1472924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated vascular endothelial growth factor pretreatment levels are correlated with the tumor burden in Hodgkin lymphoma and continue to be elevated in prolonged complete remission.
    Rueda A; Olmos D; Villareal V; Torres E; Pajares BI; Alba E
    Clin Lymphoma Myeloma; 2007 May; 7(6):400-5. PubMed ID: 17621405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
    Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
    Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
    Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
    Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
    Reiser M; Josting A; Soltani M; Staib P; Salzberger B; Diehl V; Engert A
    Leuk Lymphoma; 2002 Apr; 43(4):805-11. PubMed ID: 12153168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.
    Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Michallet AS; Warzocha K; Biliński P; Boyle P; Coiffier B; Salles G
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):165-74. PubMed ID: 23283519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
    Lossos IS; Natkunam Y; Levy R; Lopez CD
    Leuk Lymphoma; 2002 Dec; 43(12):2309-17. PubMed ID: 12613517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia.
    Sadamori N; Mine M; Hakariya S; Ichiba M; Kawachi T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
    Leukemia; 1995 Apr; 9(4):594-7. PubMed ID: 7723390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
    Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
    Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.
    Riihijärvi S; Nurmi H; Holte H; Björkholm M; Fluge O; Pedersen LM; Rydström K; Jerkeman M; Eriksson M; Leppä S
    Eur J Haematol; 2012 Nov; 89(5):395-402. PubMed ID: 22882209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
    Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients.
    Azuma M; Shi M; Danenberg KD; Gardner H; Barrett C; Jacques CJ; Sherod A; Iqbal S; El-Khoueiry A; Yang D; Zhang W; Danenberg PV; Lenz HJ
    Pharmacogenomics; 2007 Dec; 8(12):1705-13. PubMed ID: 18086000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of some biochemical markers as prognostic factors in malignant lymphomas.
    Salem HA; Eissa LA; Rabbie AM; El-Helw LM; El-Gayar AM
    Pak J Pharm Sci; 2006 Jul; 19(3):219-30. PubMed ID: 16935830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma.
    Pappa CA; Tsirakis G; Samiotakis P; Tsigaridaki M; Alegakis A; Goulidaki N; Alexandrakis MG
    Cancer Invest; 2013 Jul; 31(6):385-9. PubMed ID: 23758184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of the neopterin in serum and urine of the patients with non-Hodgkin's lymphoma].
    Cheng XC; Li HC; Zhang R; Tan J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):443-6. PubMed ID: 15972138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems.
    Lopez-Guillermo A; Montserrat E; Reverter JC; Cervantes F; Escoda L; Tassies D; Blade J; Marin P; Sierra J; Ordi J
    Leuk Lymphoma; 1993 May; 10(1-2):101-9. PubMed ID: 8374517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.